Senior Scientific Director
Pfizer Inc
David has been in the pharmaceutical industry for 31 years and currently holds the title of Senior Scientific Director as head of Drug Transporter & ADME Biomarker Sciences at Pfizer (Groton, CT, USA). Before joining Pfizer in 2014, he spent productive periods at US-based G. D. Searle and Abbott Labs (Chicago, IL), Merck (West Point, PA) and Bristol-Myers Squibb (Lawrenceville, NJ). During that time, he served on both scientific (Associate Research Fellow, Senior Research Fellow) and managerial (Director, Senior Director, Executive Director) ladders. He has authored 181 peer-reviewed manuscripts, nearly two dozen book chapters and presented at >90 venues (scientific symposia/webinars). David has also served on the editorial boards of various DMPK-related journals (e.g., Current Drug Metabolism, Drug Metabolism Letters, Xenobiotica, Drug Metabolism & Disposition). In addition, he has edited/co-edited three textbooks related to drug interactions and one on the topic of drug metabolism. At the present time, he serves as adjunct professor at the College of Pharmacy (University of Rhode Island, RI), is on the Advisory Board of the College of Pharmacy & Pharmaceutical Sciences (Washington State University, WA), and is member of the International Transporter Consortium (ITC). In 2009, David was inducted as Fellow of The American Association of Pharmaceutical Scientists (AAPS). He is the recipient of the 2021 Distinguished Accomplishments in Drug Discovery & Development Award bestowed by the International Society for the Study of Xenobiotics (ISSX).
Sunday, September 10, 2023
11:45 AM - 1:15 PM PT
Disclosure information not submitted.